Simple method for detecting fluconazole-resistant yeasts with chromogenic agar

Journal of Clinical Microbiology

Volumn 34, Issue 7, 1996, Pages 1794-1797

  Patterson, Thomas F ^a   Revankar, Sanjay G ^a   Kirkpatrick, William R ^a   Dib, Olga ^a   Fothergill, Annette W ^a   Redding, Spencer W ^a   Sutton, Deanna A ^a   Rinaldi, Michael G ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; FLUCONAZOLE;

ARTICLE; CANDIDA; CANDIDIASIS; CLINICAL ARTICLE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; PHARYNGITIS; PRIORITY JOURNAL;

EID: 0030014760     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.34.7.1794-1797.1996     Document Type: Article

References (22)

1. Barchiesi, F., A. L. Colombo, D. A. McGough, and M. G. Rinaldi. 1994. Comparative study of broth macrodilution and microdilution techniques for in vitro antifungal susceptibility testing of yeasts by using the National Committee for Clinical Laboratory Standards' proposed standard. J. Clin. Microbiol. 32:2494-2500.
2. Heighton, D., R. Ludford, D. T. Clark, S. R. Brailsford, C. L. Pankhurst, G. F. Tinsley, J. Fiske, D. Lewis, B. Daly, N. Khalifa, V. Marren, and E. Lynch. 1995. Use of CHROMagar Candida medium for isolation of yeasts from dental samples. J. Clin. Microbiol. 33:3025-3027.
3. Cameron, M. L., W. A. Schell, S. Bruch, J. A. Bartlett, H. A. Waskin, and J. R. Perfect. 1993. Correlation of in vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type 1. Antimicrob. Agents Chemother. 37: 2449-2453.
4. Chavenet, P., J. Lopez, M. Grappin, A. Bannin, M. Duong, A. Waldner, M. Buisson, P. Camerlynck, and H. Portier. 1994. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients. AIDS 8:945-950.
5. Fromtling, R. A., J. N. Galgiani, M. Pfaller, A. Espinel-Ingroff, K. F. Bartizal, M. S. Bartlett, B. A. Body, C. Frey, G. Hall, G. D. Roberts, F. B. Nolte, F. C. Odds, M. G. Rinaldi, A. M. Sugar, and K. Villareal. 1993. Multicenter evaluation of a broth macrodilution antifungal susceptibility test for yeasts. Antimicrob. Agents Chemother. 37:39-45.
6. Louwagie, B., I. Surraont, J. Verhaegen, and F. Odds. 1995. Differential and enrichment media for selective culture and recognition of yeast species from clinical material. Eur. J. Clin. Microbiol. Infect. Dis. 14:406-411.
7. Maenza, J. R., J. C. Keruly, R. D. Moore, R. E. Chaisson, W. G. Merz, and J. E. Gallant. 1996. Risk factors for fluconazole-resistant candidiasis in human immunodeficiency virus-infected patients. J. Infect. Dis. 173:219-225.
8. Millon, L., A. Manteaux, G. Reboux, C. Drobacheff, M. Monod, T. Barale, and Y. Michel-Briand. 1994. Fluconazole-resistant recurrent oral candidiasis in human immunodeficiency virus-positive patients: persistence of Candida albicans strains with the same genotype. J. Clin. Microbiol. 32:1115-1118.
9. National Committee for Clinical Laboratory Standards. 1992. Reference method for broth dilution antifungal susceptibility testing of yeasts: proposed standard. M27-P. National Committee for Clinical Laboratory Standards, Villanova, Pa.
10. Odds, F. C., and R. Bernaerts. 1994. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J. Clin. Microbiol. 32:1923-1929.
11. Pfaller, M. A., J. R. Chalberg, S. W. Redding, J. Smith, G. Farinacci, A. W. Fothergill, and M. G. Rinaldi. 1994. Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis. J. Clin. Microbiol. 32:59-64.
12. Pfaller, M. A., A. Houston, and S. Coffman. 1996. Application of CHROM-agar Candida for rapid screening of clinical specimens for Candida albicans, Candida tropicalis, Candida krusei, and Candida (Torulopsis) glabrata. J. Clin. Microbiol. 34:58-61.
13. Powderly, W. G. 1992. Mucosal candidiasis caused by non-albicans species of Candida in HIV-positive patients. AIDS 6:604-605.
14. Powderly, W. G., K. Robinson, and E. J. Keath. 1992. Molecular typing of Candida albicans isolated from oral lesions of HIV-infected individuals. AIDS 6:81-84.
15. Powderly, W. G., K. Robinson, and E. J. Keath. 1993. Molecular epidemiology of recurrent oral candidiasis in human immunodeficiency virus-positive patients: evidence for two patterns of recurrence. J. Infect. Dis. 168:463-466.
16. Redding, S., J. Smith, G. Farinacci, M. Rinaldi, A. Fothergill, J. Rhine-Chalberg, and M. Pfaller. 1994. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis. Clin. Infect. Dis. 18:240-242.
17. Rex, J. H., M. A. Pfaller, A. L. Barry, P. W. Nelson, and C. D. Webb. 1995. Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. Antimicrob. Agents Chemother. 39:40-44.
18. Rex, J. H., M. A. Pfaller, M. G. Rinaldi, A. Polak, and J. N. Galgiani. 1993. Antifungal susceptibility testing. Clin. Microbiol. Rev. 6:367-381.
19. Rex, J. H., M. G. Rinaldi, and M. A. Pfaller. 1995. Resistance of Candida species to fluconazole. Antimicrob. Agents Chemother. 39:1-8.
20. Troillet, N., C. Durussel, J. Bille, M. P. Glauser, and J. P. Chave. 1993. Correlation between in vitro susceptibility of Candida albicans and fluconazole-resistant oropharyngeal candidiasis in HIV-infected patients. Eur. J. Clin. Microbiol. Infect. Dis. 12:911-915.
21. Wingard, J. R. 1995. Importance of Candida species other than C. albicans as pathogens in oncology patients. Clin. Infect. Dis. 20:115-125.
22. Wingard, J. R., W. G. Merz, M. G. Rinaldi, T. F. Johnson, J. E. Karp, and R. Saral. 1991. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N. Engl. J. Med. 325:1274-1277.